Moleculin Biotech Inc. (NASDAQ:MBRX) Archives - BioPharmaJournal

Home Tags Moleculin Biotech Inc. (NASDAQ:MBRX)

Moleculin Biotech Inc. (NASDAQ: MBRX) Announces Preliminary Results Of Study Evaluating...

Gavins Felicity - January 6, 2022 0

Moleculin Biotech Inc. (NASDAQ:MBRX) Granted Three Rare Paediatric Disease Designations For...

Ward Sport - December 4, 2020 0

Moleculin Biotech Inc. (NASDAQ:MBRX) Receives Rare Paediatric Disease Designation For WP1066...

Matt Wade - December 3, 2020 0

Moleculin Biotech Inc. (NASDAQ:MBRX) Enters Into an Agreement with Sterling Pharma...

Gavins Felicity - July 23, 2020 0

Moleculin Biotech Inc. (NASDAQ:MBRX) Submits Expansion Request For Annamycin Study Sites...

Kate Hudson - June 15, 2020 0

Recent Post

Lucid Motors (LCID) could be a falling knife for retail traders

Kate Hudson - January 27, 2023 0

The stock of Lucid (NASDAQ:LCID) saw a significant increase on Friday, with the price nearly doubling before trading was halted. The stock...

BuzzFeed Inc (NASDAQ:BZFD) surge could be just getting started

January 26, 2023

Invesco QQQ Trust Series 1 (NASDAQ:QQQ) looks to bounce back as...

January 25, 2023

Esports Entertainment Group Inc (GMBL) could keep surging as online iGaming...

January 24, 2023

Microsoft (MSFT) post disappointing revenue forecast for current quarter

January 24, 2023